title: Adrenergic stimulation of renal prostanoids in the Lyon hypertensive rat.
abstract: Young, genetically hypertensive Lyon (LH) rats exhibited an increased renal in vivo turnover of norepinephrine and an elevated urinary excretion of thromboxane B2 when compared with normotensive (LN) and low blood pressure (LL) controls. Therefore, the effects of norepinephrine (1.2 x 10(-8) to 9.6 x 10(-7) M) and of phenylephrine (5 x 10(-8) to 1.9 x 10(-6) M) on renal function and the urinary excretion of prostanoids were assessed in isolated perfused kidneys of 8-week-old LH, LN, and LL rats. In addition, the effects of norepinephrine were assessed before and during thromboxane A2/prostaglandin H2 receptor blockade by AH23848 (4 x 10(-6) M). Before drug infusion, LH kidneys differed from those of LN and LL controls by having an elevated renal vascular resistance and a decreased natriuresis and glomerular filtration rate; the urinary output of prostaglandin E2 and F2 alpha, of 6-ketoprostaglandin F1 alpha, and of thromboxane B2 was similar in the three strains. The constrictor effects of norepinephrine and phenylephrine were significantly increased in LH rat kidneys compared with LL but not with LN controls, and their pressure-natriuresis was markedly reduced. Norepinephrine and phenylephrine induced a 10- to 20-fold dose-dependent increase in the synthesis of the four prostanoids, which was more pronounced in LH than in LN and LL rats for thromboxane B2 only. AH23848 infusion significantly reduced the vascular effects of norepinephrine and increased the natriuretic response of LH but not of LN and LL rat kidneys.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Physiology and Clinical Pharmacology, URA CNRS 606, Faculty of Pharmacy, Lyon, France.
authors.forename: K L
authors.initials: KL
authors.lastname: Liu
authors.forename: A H
authors.initials: AH
authors.lastname: Aissa
authors.forename: M C
authors.initials: MC
authors.lastname: Laréal
authors.forename: D
authors.initials: D
authors.lastname: Benzoni
authors.forename: M
authors.initials: M
authors.lastname: Vincent
authors.forename: J
authors.initials: J
authors.lastname: Sassard
mesh_terms: D000818:Animals; D006973:Hypertension / Q000378:metabolism* / Q000503:physiopathology; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology*; D010656:Phenylephrine / Q000494:pharmacology*; D011453:Prostaglandins / Q000096:biosynthesis*; D051381:Rats; D011918:Rats, Inbred SHR; D011941:Receptors, Adrenergic / Q000187:drug effects / Q000502:physiology; D013931:Thromboxanes / Q000096:biosynthesis*; D014655:Vascular Resistance / Q000187:drug effects
chemical_list: D011453:Prostaglandins; D011941:Receptors, Adrenergic; D013931:Thromboxanes; D010656:Phenylephrine; D009638:Norepinephrine